News Quantified

VCNX – vaccinex, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Vaccinex Reports 2023 Financial Results and Provides Corporate Update [Yahoo! Finance]

Vaccinex Reports 2023 Financial Results and Provides Corporate Update

Vaccinex, Inc. Announces $1.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules [Yahoo! Finance]

Vaccinex, Inc. Announces $1.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules

Vaccinex Announces Multiple New Agreements for Access to ActivMAb® Antigen Virus Technology [Yahoo! Finance]

Form S-3 VACCINEX, INC.

Form 10-K/A VACCINEX, INC. For: Dec 31

Form 4 VACCINEX, INC. For: Apr 19 Filed by: FRIEDBERG ALBERT

Form EFFECT VACCINEX, INC.

Form 424B3 VACCINEX, INC.

Top News Gainers

1/23 Form 8-K VACCINEX, INC. For: Jan 21 35.7%

3/14 Vaccinex Inc (NASDAQ: VCNX) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $5.00 price target on the stock. 19.7%

1/27 Form 4 VACCINEX, INC. For: Jan 23 Filed by: Zauderer Maurice 19.1%

11/12 Vaccinex Reports Third Quarter 2019 Financial Results and Provides Corporate Update 12.0%

9/24 Vaccinex to Present at the Ladenburg Thalmann 2019 Healthcare Conference 10.3%

8/1 Vaccinex Inc (NASDAQ: VCNX) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. 8.9%

3/11 Form 4 VACCINEX, INC. For: Mar 09 Filed by: FRIEDBERG ALBERT 7.0%

9/13 Vaccinex Inc (NASDAQ: VCNX) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. 6.5%

7/19 Form 8-K VACCINEX, INC. For: Jul 15 6.0%

12/12 Vaccinex Inc (NASDAQ: VCNX) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 5.1%

Top News Decliners

2/28 Vaccinex Inc (NASDAQ: VCNX) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. -18.3%

11/9 Vaccinex Presents Updated Interim Data from a Phase 1b/2 Study of Pepinemab (VX15/2503) in Combination with Avelumab (BAVENCIO®) in Non-Small Cell Lung Cancer at the 34th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) -11.1%

3/17 Vaccinex Inc (NASDAQ: VCNX) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -9.9%

3/23 Form 4 VACCINEX, INC. For: Mar 19 Filed by: FRIEDBERG ALBERT -9.4%

4/1 Form 4 VACCINEX, INC. For: Mar 31 Filed by: Frieberg Jacob B. -9.1%

3/26 Form 4 VACCINEX, INC. For: Mar 24 Filed by: FCMI Parent Co. -8.1%

1/27 Form SC 13D/A VACCINEX, INC. Filed by: FCMI Parent Co. -8.1%

10/19 Vaccinex Inc (NASDAQ: VCNX) had its "hold" rating re-affirmed by analysts at Zacks Investment Research. -7.7%

10/2 Form 4 VACCINEX, INC. For: Sep 30 Filed by: VACCINEX, INC. -7.2%

6/5 Vaccinex Inc (NASDAQ: VCNX) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. -7.0%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day